Dr. Gieschen on Patient Selection for Radiation in Prostate Cancer

Video

In Partnership With:

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

Holger L. Gieschen, MD, assistant professor, Department of Radiology, the University of Tennessee Health Science Center, radiation oncologist, West Cancer Center, discusses patient selection for radiation in the treatment of prostate cancer.

There are several patients who are considered eligible to receive radiation therapy, Gieschen says. Patients ranging from low-risk to high-risk disease can be treated with radiation, but there are competing modalities in this space, such as prostatectomy. Although high-risk patients are usually treated with surgery, Gieschen notes that these patients can also benefit from radiation treatment.

In the definitive setting, the goal of radiation therapy is to shrink the cancer as much as possible and potentially cure the patient, whereas in the palliative setting, this approach is used to stabilize prostate-specific antigen levels that naturally rise after surgery.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD